Gosset Ownership
Private
Employees
~201
Therapeutic Areas
Stage
Phase 1
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Forge Biologics General Information
Forge Biologics operates one of the largest dedicated AAV gene therapy manufacturing facilities in the US ("the Hearth"), providing end-to-end services from process development through cGMP/commercial production. The company’s FUEL™ platform offers significant productivity gains over industry standards. More than 50 developers have used their technologies across over 500 manufactured batches supporting more than 35 disease indications. As a hybrid CDMO/therapeutic developer, it also maintains an undisclosed proprietary pipeline of novel AAV-based gene therapies.
Contact Information
Primary Industry
Biotech
Corporate Office
Columbus, Ohio
United States
United States
Drug Pipeline
FBX-101
Phase 1Key Partnerships
Life Biosciences, Multiple unnamed biotech/pharma partners (>50 clients supported overall)
Forge Biologics Funding
No funding data available
To view Forge Biologics's complete valuation and funding history, request access »